Header Logo

Susan Lynn Hogan MD

TitleAssistant Professor
InstitutionUMass Chan Medical School
DepartmentFamily Medicine and Community Health
AddressUMass Chan Medical School
55 Lake Avenue North
Worcester MA 01655
vCardDownload vCard
    Other Positions
    InstitutionT.H. Chan School of Medicine
    DepartmentFamily Medicine and Community Health

    Collapse Biography 
    Collapse education and training
    University of New Hampshire Durham, Durham, NH, United StatesBSBiology
    New York University, New York, NY, United StatesMD

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Reynolds ML, Loehr LR, Hogan SL, Hu Y, Isasi CR, Cordero C, Ricardo AC, Lash JP, Derebail VK. Prevalence of infertility and pregnancy loss among individuals with kidney disease in the Hispanic Community Health Study/Study of Latinos. Womens Health (Lond). 2024 Jan-Dec; 20:17455057231224544. PMID: 38279825.
      Citations:    Fields:    Translation:HumansPHPublic Health
    2. Massicotte-Azarniouch D, Detwiler RK, Hu Y, Falk RJ, Saha MK, van Duin D, Hogan SL, Derebail VK. Infections Following Kidney Transplantation After Exposure to Immunosuppression for Treatment of Glomerulonephritis. Am J Kidney Dis. 2023 Dec 30. PMID: 38160700.
      Citations:    Fields:    
    3. Strasma A, Reyes ?M, Arag?n A, L?pez I, Park LP, Hogan SL, Thielman N, Wyatt C, Gonz?lez-Quiroz M. Kidney disease characteristics, prevalence, and risk factors in Le?n, Nicaragua: a population-based study. BMC Nephrol. 2023 11 12; 24(1):335. PMID: 37953252.
      Citations:    Fields:    Translation:Humans
    4. Glenn DA, Pate V, Zee J, Walter EB, Denburg MR, Hogan S, Falk RJ, Mottl A, Layton JB. Influenza Vaccine Administration and Effectiveness Among Children and Adults With Glomerular Disease. Kidney Int Rep. 2024 Feb; 9(2):257-265. PMID: 38344741.
    5. Massicotte-Azarniouch D, Detwiler RK, Hu Y, Falk RJ, Saha MK, Hogan SL, Derebail VK. Malignancy risk in kidney transplant recipients exposed to immunosuppression pre-transplant for the treatment of glomerulonephritis. Nephrol Dial Transplant. 2023 08 31; 38(9):2009-2018. PMID: 36549661.
      Citations:    Fields:    Translation:Humans
    6. Kim YH, Saha MK, Hu Y, Kumar S, Poulton CJ, Hogan SL, Nachman P, Jennette JC, Nast CC, Mottl AK. Impact of Diabetic Lesions on Pathology, Treatment, and Outcomes of Glomerular Diseases. Kidney360. 2023 10 01; 4(10):1445-1453. PMID: 37642555.
      Citations: 1     Fields:    Translation:Humans
    7. Cao B, Hogan SL, Derebail VK, Ehlert A, Thorpe CT. Polypharmacy in US Medicare beneficiaries with antineutrophil cytoplasmic antibody vasculitis. J Manag Care Spec Pharm. 2023 Jul; 29(7):770-781. PMID: 37404075.
      Citations:    Fields:    Translation:Humans
    8. Chen DP, Aiello CP, McCoy D, Stamey T, Yang J, Hogan SL, Hu Y, Derebail VK, Wu EY, Jennette JC, Falk RJ, Ciavatta DJ. PRTN3 variant correlates with increased autoantigen levels and relapse risk in PR3-ANCA versus MPO-ANCA disease. JCI Insight. 2023 02 22; 8(4). PMID: 36626226.
      Citations: 1     Fields:    Translation:Humans
    9. Kallash M, Wang Y, Smith A, Trachtman H, Gbadegesin R, Nester C, Canetta P, Wang C, Hunley TE, Sperati CJ, Selewski D, Ayoub I, Srivastava T, Mottl AK, Kopp J, Gillespie B, Robinson B, Chen D, Steinke J, Twombley K, Reidy K, Mucha K, Greenbaum LA, Blazius B, Helmuth M, Yonatan P, Parekh RS, Hogan S, Royal V, D'Agati V, Chishti A, Falk R, Gharavi A, Holzman L, Klein J, Smoyer W, Kretzler M, Gipson D, Kidd JM. Rapid Progression of Focal Segmental Glomerulosclerosis in Patients with High-Risk APOL1 Genotypes. Clin J Am Soc Nephrol. 2023 03 01; 18(3):344-355. PMID: 36763813.
      Citations:    Fields:    Translation:Humans
    10. Chen DP, Henderson CD, Anguiano J, Aiello CP, Collie MM, Moreno V, Hu Y, Hogan SL, Falk RJ. Kidney Disease Progression in Membranous Nephropathy among Black Participants with High-Risk APOL1 Genotype. Clin J Am Soc Nephrol. 2023 03 01; 18(3):337-343. PMID: 36763808.
      Citations: 1     Fields:    Translation:Humans
    11. Agosto-Burgos C, Wu EY, Iannone MA, Hu Y, Hogan SL, Henderson CD, Kennedy KB, Blazek L, Herrera CA, Munson D, Falk RJ, Ciavatta DJ, Free ME. The frequency of Treg subsets distinguishes disease activity in ANCA vasculitis. Clin Transl Immunology. 2022; 11(11):e1428. PMID: 36381498.
    12. Huang SP, Li X, Cao B, Nguyen JT, Robinson JE, Derebail VK, Hogan SL, Thorpe CT. Health care costs and utilization prior to diagnosis of antineutrophil cytoplasmic antibody vasculitis in Medicare beneficiaries. J Manag Care Spec Pharm. 2022 Nov; 28(11):1292-1303. PMID: 36282932.
      Citations: 2     Fields:    Translation:Humans
    13. Glenn DA, Zee J, Mansfield S, O'Shaughnessy MM, Bomback AS, Gibson K, Greenbaum LA, Mariani L, Falk R, Hogan S, Mottl A, Denburg MR. Immunosuppression Exposure and Risk of Infection-Related Acute Care Events in Patients With Glomerular Disease: An Observational Cohort Study. Kidney Med. 2022 Nov; 4(11):100553. PMID: 36339665.
    14. Alba MA, Jennette JC, Hu Y, Poulton CJ, Blazek L, Derebail VK, Falk RJ, Hogan SL. Relevance of Combined Clinicopathologic Phenotype and Antineutrophil Cytoplasmic Autoantibody Serotype in the Diagnosis of Antineutrophil Cytoplasmic Autoantibody Vasculitis. Kidney Int Rep. 2022 Dec; 7(12):2676-2690. PMID: 36506241.
    15. Chen DP, McInnis EA, Wu EY, Stember KG, Hogan SL, Hu Y, Henderson CD, Blazek LN, Mallal S, Karosiene E, Peters B, Sidney J, James EA, Kwok WW, Jennette JC, Ciavatta DJ, Falk RJ, Free ME. Immunological Interaction of HLA-DPB1 and Proteinase 3 in ANCA Vasculitis is Associated with Clinical Disease Activity. J Am Soc Nephrol. 2022 08; 33(8):1517-1527. PMID: 35672132.
      Citations: 7     Fields:    Translation:HumansCells
    16. Massicotte-Azarniouch D, Kotzen E, Todd S, Hu Y, Hogan SL, Jain K. Kidney thrombotic microangiopathy in lupus nephritis: Impact on treatment and prognosis. Lupus. 2022 Sep; 31(10):1175-1185. PMID: 35650019.
      Citations: 2     Fields:    Translation:Humans
    17. Glenn DA, Hogan SL. Big Data and Glomerular Disease: Uncovering Common Outcomes of Rare Disease. J Am Soc Nephrol. 2021 09; 32(9):2106-2108. PMID: 34465604.
      Citations:    Fields:    Translation:Humans
    18. Glenn DA, Zee J, Hegde A, Henderson C, O'Shaughnessy MM, Bomback A, Gibson K, Greenbaum LA, Mansfield S, Hu Y, Mariani L, Falk R, Hogan S, Denburg M, Mottl A. Validation of Diagnosis Codes to Identify Infection-Related Acute Care Events in Patients With Glomerular Disease. Kidney Int Rep. 2021 Dec; 6(12):3079-3082. PMID: 34901577.
    19. Reynolds ML, Poulton CJ, Blazek LN, Hogan SL, Falk RJ, Derebail VK. Subfertility and early menopause in women with glomerular disease. Nephrol Dial Transplant. 2021 04 26; 36(5):948-950. PMID: 33508104.
      Citations: 3     Fields:    
    20. Cooley I, Derebail VK, Gibson KL, ?lvarez C, Poulton CJ, Blazek LN, Love A, Hogan SL, Jennette JC, Falk RJ, Sheikh SZ. Association of Lupus Nephritis Histopathologic Classification With Venous Thromboembolism-Modification by Age at Biopsy. Kidney Int Rep. 2021 Jun; 6(6):1653-1660. PMID: 34169206.
    21. Chen DP, Zaky ZS, Schold JD, Herlitz LC, El-Rifai R, Drawz PE, Bruggeman LA, Barisoni L, Hogan SL, Hu Y, O'Toole JF, Poggio ED, Sedor JR. Podocyte density is reduced in kidney allografts with high-risk APOL1 genotypes at transplantation. Clin Transplant. 2021 04; 35(4):e14234. PMID: 33511679.
      Citations: 2     Fields:    Translation:HumansCells
    22. Glenn DA, Henderson CD, O'Shaughnessy M, Hu Y, Bomback A, Gibson K, Greenbaum LA, Zee J, Mariani L, Falk R, Hogan S, Mottl A. Infection-Related Acute Care Events among Patients with Glomerular Disease. Clin J Am Soc Nephrol. 2020 12 07; 15(12):1749-1761. PMID: 33082200.
      Citations: 7     Fields:    Translation:Humans
    23. Reynolds ML, Poulton CJ, Blazek LN, Hogan SL, Falk RJ, Derebail VK. Contraceptive Use and Elective Terminations in Women Enrolled in the Glomerular Disease Collaborative Network. Kidney Int Rep. 2020 Oct; 5(10):1780-1783. PMID: 33102971.
    24. Jones BE, Herrera CA, Agosto-Burgos C, Starmer J, Bass WA, Poulton CJ, Blazek L, Henderson CD, Hu Y, Hogan SL, Hu P, Xiao H, Wu EY, Chen DP, Jennette JC, Free ME, Falk RJ, Ciavatta DJ. ANCA autoantigen gene expression highlights neutrophil heterogeneity where expression in normal-density neutrophils correlates with ANCA-induced activation. Kidney Int. 2020 09; 98(3):744-757. PMID: 32446935.
      Citations: 10     Fields:    Translation:HumansCells
    25. Sanderson KR, Chang E, Bjornstad E, Hogan SL, Hu Y, Askenazi D, Fry RC, O'Shea TM. Albuminuria, Hypertension, and Reduced Kidney Volumes in Adolescents Born Extremely Premature. Front Pediatr. 2020; 8:230. PMID: 32528916.
    26. Lee T, Chung Y, Poulton CJ, Derebail VK, Hogan SL, Reich HN, Falk RJ, Nachman PH. Serum Albumin at Partial Remission Predicts Outcomes in Membranous Nephropathy. Kidney Int Rep. 2020 May; 5(5):706-717. PMID: 32405591.
    27. Wu EY, McInnis EA, Boyer-Suavet S, Mendoza CE, Aybar LT, Kennedy KB, Poulton CJ, Henderson CD, Hu Y, Hogan SL, Hu P, Xiao H, Nachman PH, Jennette JC, Falk RJ, Bunch DO. Measuring Circulating Complement Activation Products in Myeloperoxidase- and Proteinase 3-Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Arthritis Rheumatol. 2019 11; 71(11):1894-1903. PMID: 31215772.
      Citations: 16     Fields:    Translation:Humans
    28. Free ME, Stember KG, Hess JJ, McInnis EA, Lardinois O, Hogan SL, Hu Y, Mendoza C, Le AK, Guseman AJ, Pilkinton MA, Bortone DS, Cowens K, Sidney J, Karosiene E, Peters B, James E, Kwok WW, Vincent BG, Mallal SA, Jennette JC, Ciavatta DJ, Falk RJ. Restricted myeloperoxidase epitopes drive the adaptive immune response in MPO-ANCA vasculitis. J Autoimmun. 2020 01; 106:102306. PMID: 31383567.
      Citations: 12     Fields:    Translation:HumansAnimalsCells
    29. Mendoza CE, Brant EJ, McDermott ML, Froment A, Hu Y, Hogan SL, Jennette JC, Falk RJ, Nachman PH, Derebail VK, Bunch DO. Elevated Microparticle Tissue Factor Activity Differentiates Patients With Venous Thromboembolism in Anti-neutrophil Cytoplasmic Autoantibody Vasculitis. Kidney Int Rep. 2019 Nov; 4(11):1617-1629. PMID: 31891003.
    30. Nguyen JT, Roberts C, Thorpe CT, Thorpe JM, Hogan SL, McGregor J, Geryk L, Carpenter DM. Economic and objective burden of caregiving on informal caregivers of patients with systemic vasculitis. Musculoskeletal Care. 2019 06; 17(2):282-287. PMID: 30901158.
      Citations: 1     Fields:    Translation:Humans
    31. Hogan SL, Nachman PH, Poulton CJ, Hu Y, Blazek LN, Free ME, Jennette JC, Falk RJ. Understanding Long-term Remission Off?Therapy in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Kidney Int Rep. 2019 Apr; 4(4):551-560. PMID: 30993230.
    32. O'Shaughnessy MM, Hogan SL, Poulton CJ, Falk RJ, Singh HK, Nickeleit V, Jennette JC. Temporal and Demographic Trends in Glomerular Disease Epidemiology in the Southeastern United States, 1986-2015. Clin J Am Soc Nephrol. 2017 Apr 03; 12(4):614-623. PMID: 28325866.
      Citations: 60     Fields:    Translation:Humans
    33. Jones BE, Yang J, Muthigi A, Hogan SL, Hu Y, Starmer J, Henderson CD, Poulton CJ, Brant EJ, Pendergraft WF, Jennette JC, Falk RJ, Ciavatta DJ. Gene-Specific DNA Methylation Changes Predict Remission in Patients with ANCA-Associated Vasculitis. J Am Soc Nephrol. 2017 Apr; 28(4):1175-1187. PMID: 27821628.
      Citations: 23     Fields:    Translation:HumansCells
    34. Yang J, Ge H, Poulton CJ, Hogan SL, Hu Y, Jones BE, Henderson CD, McInnis EA, Pendergraft WF, Jennette JC, Falk RJ, Ciavatta DJ. Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Clin Epigenetics. 2016; 8:85. PMID: 27752292.
      Citations: 17     Fields:    Translation:HumansCells
    35. Laurin LP, Gasim AM, Derebail VK, McGregor JG, Kidd JM, Hogan SL, Poulton CJ, Detwiler RK, Jennette JC, Falk RJ, Nachman PH. Renal Survival in Patients with Collapsing Compared with Not Otherwise Specified FSGS. Clin J Am Soc Nephrol. 2016 10 07; 11(10):1752-1759. PMID: 27445167.
      Citations: 16     Fields:    Translation:Humans
    36. Rhee RL, Hogan SL, Poulton CJ, McGregor JA, Landis JR, Falk RJ, Merkel PA. Trends in Long-Term Outcomes Among Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Renal Disease. Arthritis Rheumatol. 2016 07; 68(7):1711-20. PMID: 26814428.
      Citations: 46     Fields:    Translation:Humans
    37. Lee T, Derebail VK, Kshirsagar AV, Chung Y, Fine JP, Mahoney S, Poulton CJ, Lionaki S, Hogan SL, Falk RJ, Cattran DC, Hladunewich M, Reich HN, Nachman PH. Patients with primary membranous nephropathy are at high risk of cardiovascular events. Kidney Int. 2016 May; 89(5):1111-1118. PMID: 26924046.
      Citations: 19     Fields:    Translation:Humans
    38. Laurin LP, Gasim AM, Poulton CJ, Hogan SL, Jennette JC, Falk RJ, Foster BJ, Nachman PH. Treatment with Glucocorticoids or Calcineurin Inhibitors in Primary FSGS. Clin J Am Soc Nephrol. 2016 Mar 07; 11(3):386-94. PMID: 26912551.
      Citations: 21     Fields:    Translation:Humans
    39. Jobson MA, Hogan SL, Maxwell CS, Hu Y, Hladik GA, Falk RJ, Beuhler MC, Pendergraft WF. Clinical Features of Reported Ethylene Glycol Exposures in the United States. PLoS One. 2015; 10(11):e0143044. PMID: 26566024.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    40. Lebov JF, Engel LS, Richardson D, Hogan SL, Sandler DP, Hoppin JA. Pesticide exposure and end-stage renal disease risk among wives of pesticide applicators in the Agricultural Health Study. Environ Res. 2015 Nov; 143(Pt A):198-210. PMID: 26505650.
      Citations: 19     Fields:    Translation:HumansPHPublic Health
    41. Lebov JF, Engel LS, Richardson D, Hogan SL, Hoppin JA, Sandler DP. Pesticide use and risk of end-stage renal disease among licensed pesticide applicators in the Agricultural Health Study. Occup Environ Med. 2016 Jan; 73(1):3-12. PMID: 26177651.
      Citations: 47     Fields:    Translation:HumansPHPublic HealthCTClinical Trials
    42. Bunch DO, Mendoza CE, Aybar LT, Kotzen ES, Colby KR, Hu Y, Hogan SL, Poulton CJ, Schmitz JL, Falk RJ, Nachman PH, Pendergraft WF, McGregor JG. Gleaning relapse risk from B cell phenotype: decreased CD5+ B cells portend a shorter time to relapse after B cell depletion in patients with ANCA-associated vasculitis. Ann Rheum Dis. 2015 Sep; 74(9):1784-6. PMID: 25934841.
      Citations: 11     Fields:    Translation:HumansCells
    43. McGregor JG, Negrete-Lopez R, Poulton CJ, Kidd JM, Katsanos SL, Goetz L, Hu Y, Nachman PH, Falk RJ, Hogan SL. Adverse events and infectious burden, microbes and temporal outline from immunosuppressive therapy in antineutrophil cytoplasmic antibody-associated vasculitis with native renal function. Nephrol Dial Transplant. 2015 Apr; 30 Suppl 1:i171-81. PMID: 25805747.
      Citations: 32     Fields:    Translation:HumansCells
    44. McGregor JG, Hogan SL, Kotzen ES, Poulton CJ, Hu Y, Negrete-Lopez R, Kidd JM, Katsanos SL, Bunch DO, Nachman PH, Falk RJ. Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitis. Nephrol Dial Transplant. 2015 Apr; 30 Suppl 1:i123-31. PMID: 25805743.
      Citations: 9     Fields:    Translation:Humans
    45. Lebov JF, Valladares E, Pe?a R, Pe?a EM, Sanoff SL, Cisneros EC, Colindres RE, Morgan DR, Hogan SL. A population-based study of prevalence and risk factors of chronic kidney disease in Le?n, Nicaragua. Can J Kidney Health Dis. 2015; 2:6. PMID: 25926994.
    46. Cao Y, Liu K, Tian Z, Hogan SL, Yang J, Poulton CJ, Falk RJ, Li W. PTPN22 R620W polymorphism and ANCA disease risk in white populations: a metaanalysis. J Rheumatol. 2015 Feb; 42(2):292-9. PMID: 25448792.
      Citations: 7     Fields:    Translation:Humans
    47. Berg EA, McGregor JG, Burkart ME, Poulton CJ, Hu Y, Falk RJ, Hogan SL. What Everybody is Doing but No One is Talking About: Use of Complementary and Alternative Medicine in the ANCA Associated Vasculitis Population. J Autoimmune Dis Rheumatol. 2014 Nov 01; 2(3):74-91. PMID: 25599078.
    48. Joy MS, Roberts BV, Wang J, Hu Y, Hogan SL, Falk RJ. A pilot study of leukocyte expression patterns for drug metabolizing enzyme and transporter transcripts in autoimmune glomerulonephritis. Int J Clin Pharmacol Ther. 2014 Apr; 52(4):303-13. PMID: 24548980.
      Citations: 2     Fields:    Translation:HumansCells
    49. Lee T, Gasim A, Derebail VK, Chung Y, McGregor JG, Lionaki S, Poulton CJ, Hogan SL, Jennette JC, Falk RJ, Nachman PH. Predictors of treatment outcomes in ANCA-associated vasculitis with severe kidney failure. Clin J Am Soc Nephrol. 2014 May; 9(5):905-13. PMID: 24578329.
      Citations: 50     Fields:    Translation:Humans
    50. Derebail VK, Lacson EK, Kshirsagar AV, Key NS, Hogan SL, Hakim RM, Mooney A, Jani CM, Johnson C, Hu Y, Falk RJ, Lazarus JM. Sickle trait in African-American hemodialysis patients and higher erythropoiesis-stimulating agent dose. J Am Soc Nephrol. 2014 Apr; 25(4):819-26. PMID: 24459231.
      Citations: 9     Fields:    Translation:Humans
    51. Lee T, Biddle AK, Lionaki S, Derebail VK, Barbour SJ, Tannous S, Hladunewich MA, Hu Y, Poulton CJ, Mahoney SL, Charles Jennette J, Hogan SL, Falk RJ, Cattran DC, Reich HN, Nachman PH. Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy. Kidney Int. 2014 Jun; 85(6):1412-20. PMID: 24336031.
      Citations: 32     Fields:    Translation:Humans
    52. Geetha D, Poulton CJ, Hu Y, Seo P, McGregor JA, Falk RJ, Hogan SL. Clinical characteristics and outcome of pauci-immune glomerulonephritis in African Americans. Semin Arthritis Rheum. 2014 Jun; 43(6):778-83. PMID: 24387818.
      Citations: 3     Fields:    Translation:Humans
    53. Free ME, Bunch DO, McGregor JA, Jones BE, Berg EA, Hogan SL, Hu Y, Preston GA, Jennette JC, Falk RJ, Su MA. Patients with antineutrophil cytoplasmic antibody-associated vasculitis have defective Treg cell function exacerbated by the presence of a suppression-resistant effector cell population. Arthritis Rheum. 2013 Jul; 65(7):1922-33. PMID: 23553415.
      Citations: 66     Fields:    Translation:HumansCells
    54. Roth AJ, Ooi JD, Hess JJ, van Timmeren MM, Berg EA, Poulton CE, McGregor J, Burkart M, Hogan SL, Hu Y, Winnik W, Nachman PH, Stegeman CA, Niles J, Heeringa P, Kitching AR, Holdsworth S, Jennette JC, Preston GA, Falk RJ. Epitope specificity determines pathogenicity and detectability in ANCA-associated vasculitis. J Clin Invest. 2013 Apr; 123(4):1773-83. PMID: 23549081.
      Citations: 90     Fields:    Translation:HumansAnimalsCells
    55. Gadegbeku CA, Gipson DS, Holzman LB, Ojo AO, Song PX, Barisoni L, Sampson MG, Kopp JB, Lemley KV, Nelson PJ, Lienczewski CC, Adler SG, Appel GB, Cattran DC, Choi MJ, Contreras G, Dell KM, Fervenza FC, Gibson KL, Greenbaum LA, Hernandez JD, Hewitt SM, Hingorani SR, Hladunewich M, Hogan MC, Hogan SL, Kaskel FJ, Lieske JC, Meyers KE, Nachman PH, Nast CC, Neu AM, Reich HN, Sedor JR, Sethna CB, Trachtman H, Tuttle KR, Zhdanova O, Zilleruelo GE, Kretzler M. Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach. Kidney Int. 2013 Apr; 83(4):749-56. PMID: 23325076.
      Citations: 159     Fields:    Translation:Humans
    56. Carpenter DM, Hogan SL, Devellis RF. Predictors of medication non-adherence for vasculitis patients. Clin Rheumatol. 2013 May; 32(5):649-57. PMID: 23314654.
      Citations: 7     Fields:    Translation:Humans
    57. Bunch DO, McGregor JG, Khandoobhai NB, Aybar LT, Burkart ME, Hu Y, Hogan SL, Poulton CJ, Berg EA, Falk RJ, Nachman PH. Decreased CD5? B cells in active ANCA vasculitis and relapse after rituximab. Clin J Am Soc Nephrol. 2013 Mar; 8(3):382-91. PMID: 23293123.
      Citations: 41     Fields:    Translation:HumansCells
    58. Mottl AK, Kwon KS, Mauer M, Mayer-Davis EJ, Hogan SL, Kshirsagar AV. Normoalbuminuric diabetic kidney disease in the U.S. population. J Diabetes Complications. 2013 Mar-Apr; 27(2):123-7. PMID: 23182925.
      Citations: 34     Fields:    Translation:Humans
    59. Lionaki S, Blyth ER, Hogan SL, Hu Y, Senior BA, Jennette CE, Nachman PH, Jennette JC, Falk RJ. Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis. Arthritis Rheum. 2012 Oct; 64(10):3452-62. PMID: 23023777.
      Citations: 139     Fields:    Translation:Humans
    60. Joy MS, La M, Wang J, Bridges AS, Hu Y, Hogan SL, Frye RF, Blaisdell J, Goldstein JA, Dooley MA, Brouwer KL, Falk RJ. Cyclophosphamide and 4-hydroxycyclophosphamide pharmacokinetics in patients with glomerulonephritis secondary to lupus and small vessel vasculitis. Br J Clin Pharmacol. 2012 Sep; 74(3):445-55. PMID: 22380717.
      Citations: 23     Fields:    Translation:Humans
    61. Cao Y, Yang J, Colby K, Hogan SL, Hu Y, Jennette CE, Berg EA, Zhang Y, Jennette JC, Falk RJ, Preston GA. High basal activity of the PTPN22 gain-of-function variant blunts leukocyte responsiveness negatively affecting IL-10 production in ANCA vasculitis. PLoS One. 2012; 7(8):e42783. PMID: 22880107.
      Citations: 22     Fields:    Translation:HumansCells
    62. Ferris ME, Harward DH, Bickford K, Layton JB, Ferris MT, Hogan SL, Gipson DS, McCoy LP, Hooper SR. A clinical tool to measure the components of health-care transition from pediatric care to adult care: the UNC TR(x)ANSITION scale. Ren Fail. 2012; 34(6):744-53. PMID: 22583152.
      Citations: 53     Fields:    Translation:HumansPHPublic Health
    63. Carpenter DM, Meador AE, Elstad EA, Hogan SL, DeVellis RF. The impact of vasculitis on patients' social participation and friendships. Clin Exp Rheumatol. 2012 Jan-Feb; 30(1 Suppl 70):S15-21. PMID: 22325346.
      Citations: 12     Fields:    Translation:Humans
    64. McGregor JG, Hogan SL, Hu Y, Jennette CE, Falk RJ, Nachman PH. Glucocorticoids and relapse and infection rates in anti-neutrophil cytoplasmic antibody disease. Clin J Am Soc Nephrol. 2012 Feb; 7(2):240-7. PMID: 22134625.
      Citations: 42     Fields:    Translation:Humans
    65. Lionaki S, Derebail VK, Hogan SL, Barbour S, Lee T, Hladunewich M, Greenwald A, Hu Y, Jennette CE, Jennette JC, Falk RJ, Cattran DC, Nachman PH, Reich HN. Venous thromboembolism in patients with membranous nephropathy. Clin J Am Soc Nephrol. 2012 Jan; 7(1):43-51. PMID: 22076873.
      Citations: 70     Fields:    Translation:Humans
    66. Roth AJ, Brown MC, Smith RN, Badhwar AK, Parente O, Chung Hc, Bunch DO, McGregor JG, Hogan SL, Hu Y, Yang JJ, Berg EA, Niles J, Jennette JC, Preston GA, Falk RJ. Anti-LAMP-2 antibodies are not prevalent in patients with antineutrophil cytoplasmic autoantibody glomerulonephritis. J Am Soc Nephrol. 2012 Mar; 23(3):545-55. PMID: 22021709.
      Citations: 42     Fields:    Translation:HumansAnimalsCells
    67. Carpenter DM, DeVellis RF, Hogan SL, Fisher EB, DeVellis BM, Jordan JM. Use and perceived credibility of medication information sources for patients with a rare illness: differences by gender. J Health Commun. 2011 Jul; 16(6):629-42. PMID: 21476166.
      Citations: 20     Fields:    Translation:Humans
    68. Cao Y, Schmitz JL, Yang J, Hogan SL, Bunch D, Hu Y, Jennette CE, Berg EA, Arnett FC, Jennette JC, Falk RJ, Preston GA. DRB1*15 allele is a risk factor for PR3-ANCA disease in African Americans. J Am Soc Nephrol. 2011 Jun; 22(6):1161-7. PMID: 21617122.
      Citations: 34     Fields:    Translation:Humans
    69. Carpenter DM, Kadis JA, Devellis RF, Hogan SL, Jordan JM. The effect of medication-related support on the quality of life of patients with vasculitis in relapse and remission. J Rheumatol. 2011 Apr; 38(4):709-15. PMID: 21285174.
      Citations: 9     Fields:    Translation:Humans
    70. Layton JB, Hogan SL, Jennette CE, Kenderes B, Krisher J, Jennette JC, McClellan WM. Discrepancy between Medical Evidence Form 2728 and renal biopsy for glomerular diseases. Clin J Am Soc Nephrol. 2010 Nov; 5(11):2046-52. PMID: 20688886.
      Citations: 36     Fields:    Translation:Humans
    71. Joy MS, Boyette T, Hu Y, Wang J, La M, Hogan SL, Stewart PW, Falk RJ, Dooley MA, Smith PC. Effects of uridine diphosphate glucuronosyltransferase 2B7 and 1A7 pharmacogenomics and patient clinical parameters on steady-state mycophenolic acid pharmacokinetics in glomerulonephritis. Eur J Clin Pharmacol. 2010 Nov; 66(11):1119-30. PMID: 20567810.
      Citations: 5     Fields:    Translation:Humans
    72. Jennette CE, Vupputuri S, Hogan SL, Shoham DA, Falk RJ, Harward DH. Community perspectives on kidney disease and health promotion from at-risk populations in rural North Carolina, USA. Rural Remote Health. 2010 Apr-Jun; 10(2):1388. PMID: 20504048.
      Citations: 10     Fields:    Translation:Humans
    73. Carpenter DM, DeVellis RF, Fisher EB, DeVellis BM, Hogan SL, Jordan JM. The effect of conflicting medication information and physician support on medication adherence for chronically ill patients. Patient Educ Couns. 2010 Nov; 81(2):169-76. PMID: 20044230.
      Citations: 35     Fields:    Translation:Humans
    74. Gibson KL, Gipson DS, Massengill SA, Dooley MA, Primack WA, Ferris MA, Hogan SL. Predictors of relapse and end stage kidney disease in proliferative lupus nephritis: focus on children, adolescents, and young adults. Clin J Am Soc Nephrol. 2009 Dec; 4(12):1962-7. PMID: 19820130.
      Citations: 22     Fields:    Translation:Humans
    75. Joy MS, Dornbrook-Lavender K, Blaisdell J, Hilliard T, Boyette T, Hu Y, Hogan SL, Candiani C, Falk RJ, Goldstein JA. CYP2C9 genotype and pharmacodynamic responses to losartan in patients with primary and secondary kidney diseases. Eur J Clin Pharmacol. 2009 Sep; 65(9):947-53. PMID: 19669737.
      Citations: 15     Fields:    Translation:Humans
    76. Lionaki S, Hogan SL, Jennette CE, Hu Y, Hamra JB, Jennette JC, Falk RJ, Nachman PH. The clinical course of ANCA small-vessel vasculitis on chronic dialysis. Kidney Int. 2009 Sep; 76(6):644-51. PMID: 19536079.
      Citations: 38     Fields:    Translation:Humans
    77. Joy MS, Hilliard T, Hu Y, Hogan SL, Wang J, Falk RJ, Smith PC. Influence of clinical and demographic variables on mycophenolic acid pharmacokinetics in antineutrophil cytoplasmic antibody-associated vasculitis. Ann Pharmacother. 2009 Jun; 43(6):1020-7. PMID: 19491317.
      Citations: 8     Fields:    Translation:HumansCTClinical Trials
    78. Carpenter DM, Thorpe CT, Lewis M, Devellis RF, Hogan SL. Health-related quality of life for patients with vasculitis and their spouses. Arthritis Rheum. 2009 Feb 15; 61(2):259-65. PMID: 19177525.
      Citations: 20     Fields:    Translation:Humans
    79. Joy MS, Hilliard T, Hu Y, Hogan SL, Dooley MA, Falk RJ, Smith PC. Pharmacokinetics of mycophenolic acid in patients with lupus nephritis. Pharmacotherapy. 2009 Jan; 29(1):7-16. PMID: 19113793.
      Citations: 13     Fields:    Translation:HumansCTClinical Trials
    80. Pagnoux C, Hogan SL, Chin H, Jennette JC, Falk RJ, Guillevin L, Nachman PH. Predictors of treatment resistance and relapse in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis: comparison of two independent cohorts. Arthritis Rheum. 2008 Sep; 58(9):2908-18. PMID: 18759282.
      Citations: 91     Fields:    Translation:Humans
    81. Bautz DJ, Preston GA, Lionaki S, Hewins P, Wolberg AS, Yang JJ, Hogan SL, Chin H, Moll S, Jennette JC, Falk RJ. Antibodies with dual reactivity to plasminogen and complementary PR3 in PR3-ANCA vasculitis. J Am Soc Nephrol. 2008 Dec; 19(12):2421-9. PMID: 18701607.
      Citations: 32     Fields:    Translation:Humans
    82. Bunch DO, Silver JS, Majure MC, Sullivan P, Alcorta DA, Chin H, Hogan SL, Lindstrom YI, Clarke SH, Falk RJ, Nachman PH. Maintenance of tolerance by regulation of anti-myeloperoxidase B cells. J Am Soc Nephrol. 2008 Sep; 19(9):1763-73. PMID: 18650487.
      Citations: 4     Fields:    Translation:AnimalsCells
    83. Yang J, Bautz DJ, Lionaki S, Hogan SL, Chin H, Tisch RM, Schmitz JL, Pressler BM, Jennette JC, Falk RJ, Preston GA. ANCA patients have T cells responsive to complementary PR-3 antigen. Kidney Int. 2008 Nov; 74(9):1159-69. PMID: 18596726.
      Citations: 23     Fields:    Translation:HumansCells
    84. Nicholas MW, Dooley MA, Hogan SL, Anolik J, Looney J, Sanz I, Clarke SH. A novel subset of memory B cells is enriched in autoreactivity and correlates with adverse outcomes in SLE. Clin Immunol. 2008 Feb; 126(2):189-201. PMID: 18077220.
      Citations: 55     Fields:    Translation:HumansCells
    85. Lionaki S, Hogan SL, Falk RJ, Joy MS, Jennette CE, Nachman PH, Jennette JC. Vasculitis and anti-thyroid medication. Nephrol Dial Transplant. 2008 May; 23(5):1766-8; author reply 1768. PMID: 18424466.
      Citations:    Fields:    Translation:Humans
    86. Joy MS, Dornbrook-Lavender KA, Chin H, Hogan SL, Denu-Ciocca C. Effects of atorvastatin on Lp(a) and lipoprotein profiles in hemodialysis patients. Ann Pharmacother. 2008 Jan; 42(1):9-15. PMID: 18000162.
      Citations: 5     Fields:    Translation:Humans
    87. Ferris M, Hogan SL, Chin H, Shoham DA, Gipson DS, Gibson K, Yilmaz S, Falk RJ, Jennette JC. Obesity, albuminuria, and urinalysis findings in US young adults from the Add Health Wave III study. Clin J Am Soc Nephrol. 2007 Nov; 2(6):1207-14. PMID: 17942783.
      Citations: 27     Fields:    Translation:Humans
    88. Lionaki S, Hogan SL, Falk RJ, Joy MS, Chin H, Jennette CE, Jennette JC, Nachman PH. Association between thyroid disease and its treatment with ANCA small-vessel vasculitis: a case-control study. Nephrol Dial Transplant. 2007 Dec; 22(12):3508-15. PMID: 17686815.
      Citations: 26     Fields:    Translation:Humans
    89. Joy MS, Candiani C, Vaillancourt BA, Chin H, Hogan SL, Falk RJ. Reengineering clinical operations in a medical practice to optimize the management of anemia of chronic kidney disease. Pharmacotherapy. 2007 May; 27(5):734-44. PMID: 17461709.
      Citations: 3     Fields:    Translation:Humans
    90. Joy MS, Hogan SL, Thompson BD, Finn WF, Nickeleit V. Cytochrome P450 3A5 expression in the kidneys of patients with calcineurin inhibitor nephrotoxicity. Nephrol Dial Transplant. 2007 Jul; 22(7):1963-8. PMID: 17395652.
      Citations: 24     Fields:    Translation:HumansCells
    91. Hogan SL, Cooper GS, Savitz DA, Nylander-French LA, Parks CG, Chin H, Jennette CE, Lionaki S, Jennette JC, Falk RJ. Association of silica exposure with anti-neutrophil cytoplasmic autoantibody small-vessel vasculitis: a population-based, case-control study. Clin J Am Soc Nephrol. 2007 Mar; 2(2):290-9. PMID: 17699427.
      Citations: 46     Fields:    Translation:HumansPHPublic Health
    92. Hogan SL, Vupputuri S, Guo X, Cai J, Colindres RE, Heiss G, Coresh J. Association of cigarette smoking with albuminuria in the United States: the third National Health and Nutrition Examination Survey. Ren Fail. 2007; 29(2):133-42. PMID: 17365926.
      Citations: 17     Fields:    Translation:Humans
    93. Hogan SL, Falk RJ, Nachman PH, Jennette JC. Various forms of life in antineutrophil cytoplasmic antibody-associated vasculitis. Ann Intern Med. 2006 Mar 07; 144(5):377-8; author reply 378-9. PMID: 16520483.
      Citations: 2     Fields:    Translation:Humans
    94. Kshirsagar AV, Shoham DA, Bang H, Hogan SL, Simpson RJ, Colindres RE. The effect of cholesterol reduction with cholestyramine on renal function. Am J Kidney Dis. 2005 Nov; 46(5):812-9. PMID: 16253720.
      Citations: 3     Fields:    Translation:Humans
    95. Hogan SL, Falk RJ, Chin H, Cai J, Jennette CE, Jennette JC, Nachman PH. Predictors of relapse and treatment resistance in antineutrophil cytoplasmic antibody-associated small-vessel vasculitis. Ann Intern Med. 2005 Nov 01; 143(9):621-31. PMID: 16263884.
      Citations: 154     Fields:    Translation:Humans
    96. Joy MS, Hogan SL, Jennette JC, Falk RJ, Nachman PH. A pilot study using mycophenolate mofetil in relapsing or resistant ANCA small vessel vasculitis. Nephrol Dial Transplant. 2005 Dec; 20(12):2725-32. PMID: 16188901.
      Citations: 32     Fields:    Translation:Humans
    97. Joy MS, Nickeleit V, Hogan SL, Thompson BD, Finn WF. Calcineurin inhibitor-induced nephrotoxicity and renal expression of P-glycoprotein. Pharmacotherapy. 2005 Jun; 25(6):779-89. PMID: 15927895.
      Citations: 15     Fields:    Translation:Humans
    98. Dornbrook-Lavender KA, Joy MS, Denu-Ciocca CJ, Chin H, Hogan SL, Pieper JA. Effects of atorvastatin on low-density lipoprotein cholesterol phenotype and C-reactive protein levels in patients undergoing long-term dialysis. Pharmacotherapy. 2005 Mar; 25(3):335-44. PMID: 15843280.
      Citations: 6     Fields:    Translation:HumansCTClinical Trials
    99. Yang JJ, Pendergraft WF, Alcorta DA, Nachman PH, Hogan SL, Thomas RP, Sullivan P, Jennette JC, Falk RJ, Preston GA. Circumvention of normal constraints on granule protein gene expression in peripheral blood neutrophils and monocytes of patients with antineutrophil cytoplasmic autoantibody-associated glomerulonephritis. J Am Soc Nephrol. 2004 Aug; 15(8):2103-14. PMID: 15284296.
      Citations: 41     Fields:    Translation:HumansCells
    100. Klemmer PJ, Chalermskulrat W, Reif MS, Hogan SL, Henke DC, Falk RJ. Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis. Am J Kidney Dis. 2003 Dec; 42(6):1149-53. PMID: 14655185.
      Citations: 67     Fields:    Translation:Humans
    101. Waga I, Yamamoto J, Sasai H, Munger WE, Hogan SL, Preston GA, Sun HW, Jennette JC, Falk RJ, Alcorta DA. Altered mRNA expression in renal biopsy tissue from patients with IgA nephropathy. Kidney Int. 2003 Oct; 64(4):1253-64. PMID: 12969143.
      Citations: 5     Fields:    Translation:HumansCells
    102. Segelmark M, Phillips BD, Hogan SL, Falk RJ, Jennette JC. Monitoring proteinase 3 antineutrophil cytoplasmic antibodies for detection of relapses in small vessel vasculitis. Clin Diagn Lab Immunol. 2003 Sep; 10(5):769-74. PMID: 12965902.
      Citations: 8     Fields:    Translation:Humans
    103. Franceschini N, Hogan SL, Falk RJ. Primum non nocere: Should adults with idiopathic FSGS receive steroids? Semin Nephrol. 2003 Mar; 23(2):229-33. PMID: 12704583.
      Citations: 3     Fields:    Translation:Humans
    104. Gipson DS, Ferris ME, Dooley MA, Huang K, Hogan SL. Renal transplantation in children with lupus nephritis. Am J Kidney Dis. 2003 Feb; 41(2):455-63. PMID: 12552510.
      Citations: 6     Fields:    Translation:Humans
    105. Hogan SL, Satterly KK, Dooley MA, Nachman PH, Jennette JC, Falk RJ. Silica exposure in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and lupus nephritis. J Am Soc Nephrol. 2001 Jan; 12(1):134-142. PMID: 11134259.
      Citations: 46     Fields:    Translation:Humans
    106. Kshirsagar AV, Hogan SL, Mandelkehr L, Falk RJ. Length of stay and costs for hospitalized hemodialysis patients: nephrologists versus internists. J Am Soc Nephrol. 2000 Aug; 11(8):1526-1533. PMID: 10906167.
      Citations: 9     Fields:    Translation:Humans
    Hogan's Networks
    Click the
    buttons for more information and interactive visualizations!
    Concepts (411)
    Similar People (60)
    Same Department Expand Description
    Physical Neighbors